基于OCT的生物标志物预测抗VEGF注射治疗中心受累型糖尿病黄斑水肿眼治疗反应:一项真实世界视网膜门诊研究
该回顾性队列研究纳入香港196只中心受累型糖尿病黄斑水肿眼,评估基线及治疗后SD-OCT生物标志物变化能否预测抗VEGF治疗后的视力结局。结果显示基线DRIL、视网膜高反射灶及ELM/EZ和COST破坏与较差基线及后续视力相关;治疗后DRIL、ELM/EZ和COST破坏改善与12个月视力改善相关;囊样黄斑水肿和浆液性视网膜脱离形态更可能达到黄斑中心凹亚区厚度至少降低20%。作者提出一种可在真实世界眼科门诊使用的SD-OCT评估系统以改善糖尿病黄斑水肿管理决策。
要点
- 基线DRIL、视网膜高反射灶及ELM/EZ和COST破坏与治疗后24个月内较差视力相关。
- 治疗后DRIL(p=0.048)、ELM/EZ(p=0.001)和COST(p=0.002)破坏改善与12个月视力改善相关。
- 囊样黄斑水肿(p=0.003,OR=8.18)和浆液性视网膜脱离(p=0.011,OR=4.84)形态更可能达到黄斑中心凹亚区厚度至少降低20%。
核心结论
- 基线SD-OCT生物标志物及其后续变化可预测抗VEGF注射治疗的中心受累型糖尿病黄斑水肿眼的视力和视力改善。
- 作者提出一种可在真实世界眼科门诊使用的SD-OCT评估系统,以改善糖尿病黄斑水肿管理决策。
研究设计与样本
- 回顾性队列研究,在中国香港开展。
- 纳入2011年1月1日至2018年6月30日期间接受抗VEGF注射的中心受累型糖尿病黄斑水肿眼196只。
- 回顾性获取参与者医疗记录,包括基线、6、12和24个月视力以及抗VEGF治疗开始前和完成后的SD-OCT。
- 评估SD-OCT图像的糖尿病黄斑水肿形态、玻璃体黄斑状态、视网膜内层结构紊乱(DRIL)存在、视网膜内囊肿大小、外界膜(ELM)、椭圆体带(EZ)和视锥外节尖端(COST)可见性以及视网膜或脉络膜高反射灶存在。
主要发现
- 基线DRIL、视网膜高反射灶及ELM/EZ和COST破坏的存在与较差基线及治疗后直至24个月的后续视力相关。
- 治疗后DRIL(p=0.048)、ELM/EZ(p=0.001)和COST(p=0.002)破坏改善与12个月视力改善相关。
- 囊样黄斑水肿形态眼(p=0.003,OR=8.18)和浆液性视网膜脱离形态眼(p=0.011,OR=4.84)更可能达到黄斑中心凹亚区厚度至少降低20%。
临床怎么用
- 作者提出一种可在真实世界眼科门诊使用的SD-OCT评估系统,以改善糖尿病黄斑水肿管理决策。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/AIMS: To determine whether a combination of baseline and change in spectral domain-optical coherence tomography (SD-OCT)-based biomarkers can predict visual outcomes in eyes with diabetic macular oedema (DMO) treated with antivascular endothelial growth factors (VEGF) injections. METHODS: This is a retrospective cohort study conducted in Hong Kong, China. 196 eyes with centre-involving DMO, who received anti-VEGF injections between 1 January 2011 and 30 June 2018 were recruited. Medical records of the participants were retrieved retrospectively, visual acuity (VA) at baseline, 6, 12 and 24 months and SD-OCT before initiation and after completion of anti-VEGF treatment were obtained. The SD-OCT images were evaluated for the morphology of DMO, vitreomacular status, presence of disorganisation of retinal inner layers (DRIL), sizes of intraretinal cysts, visibility of external limiting membrane (ELM), ellipsoid zone (EZ) and cone outer segment tip (COST) and the presence of hyper-reflective foci in retina or the choroid. RESULTS: The presence of baseline DRIL, hyper-reflective foci in retina and disruption of ELM/EZ and COST were associated with worse baseline and subsequent VA up to 24 months after treatment. Improvement in DRIL (p=0.048), ELM/EZ (p=0.001) and COST (p=0.002) disruption after treatment was associated with greater improvement in VA at 12 months. Eyes with cystoid macular oedema (p=0.003, OR=8.18) and serous retinal detachment (p=0.011, OR=4.84) morphology were more likely to achieve at least 20% reduction in central subfield thickness. CONCLUSION AND RELEVANCE: Baseline SD-OCT biomarkers and their subsequent change predict VA and improvement in vision in eyes with DMO treated with anti-VEGF injections. We proposed an SD-OCT-based system that can be readily used in real-life eye clinics to improve decision making in the management of DMO.
引用
- Szeto SK, Hui VWK, Tang FY, et al. OCT-based biomarkers for predicting treatment response in eyes with centre-involved diabetic macular oedema treated with anti-VEGF injections: a real-life retina clinic-based study. Br J Ophthalmol. 2021. PMID: 34750100. doi:10.1136/bjophthalmol-2021-319587
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。